《中国期刊全文数据库》收录期刊
《中国核心期刊(遴选)数据库》收录期刊
《中文科技期刊数据库》收录期刊

外科研究与新技术(中英文) ›› 2024, Vol. 13 ›› Issue (3): 181-185.doi: 10.3969/j.issn.2095-378X.2024.03.001

• 述评 • 上一篇    下一篇

先天性胫骨假关节的临床治疗新进展

吴春星, 宁波   

  1. 复旦大学附属儿科医院儿骨科, 上海 201102
  • 收稿日期:2024-07-17 发布日期:2024-10-17
  • 通讯作者: 宁波,电子信箱:ningbo@fudan.edu.cn
  • 作者简介:吴春星(1984—),男,博士,主治医师,从事临床儿骨科工作
  • 基金资助:
    国家自然科学基金(82272441); 上海市科学技术委员会科技创新行动(22Y11912200)

Recent advances on clinical treatment of congenital pseudarthrosis of the tibia

WU Chunxing, NING Bo   

  1. Department of Pediatric Orthopedics, Children’s Hospital of Fudan University, Shanghai 201102, China
  • Received:2024-07-17 Published:2024-10-17

摘要: 先天性胫骨假关节是罕见的先天性胫腓骨骨骼畸形,以骨不连、假关节形成、肢体成角短缩等畸形为主要表现,多合并神经纤维瘤病,治疗极其困难。近年来,随着对先天性胫骨假关节发病机制研究的深入,新型手术方法如胫腓骨“4合1融合术”、“Cross-union内固定法”(胫腓骨交叉融合术)的开展,结合新型药物如双膦酸盐、骨形态发生蛋白的综合使用,其骨愈合率逐渐提高,再骨折发生率降低。本文总结了近年来先天性胫骨假关节治疗的现状及进展,以期为临床治疗提供借鉴和思考。

关键词: 先天性胫骨假关节, 4合1融合术, Cross-union内固定法, 胫腓骨交叉融合术, 骨形态发生蛋白

Abstract: Congenital pseudarthrosis of the tibia(CPT) is a rare tibia disease in children's orthopedics, which is prone to bone nonunion, pseudarthrosis, and lower limb deformity, and is difficult to cure. Successful treatment remains challenging for orthopedic surgeons, despite many treatments developed for this disease. In recent years, with the in-depth study of CPT, the invention of new surgical methods such as "4-in-1 fusion" and "Cross-union" of tibia and fibula, and the comprehensive use of new drugs such as bisphosphonates and bone morphogenetic proteins, the cure rate has gradually increased and the rate of refracture has reduced. The present status and progress of treatment of CPT in recent years were summarized in this paper, aiming to provide reference for clinical treatment.

Key words: Congenital pseudarthrosis of the tibia, 4 in 1 fusion, Cross-union, Tibiofibula cross fusion, Bone morphogenetic proteins

中图分类号: